Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19

Martin-Vicente, MariaBerenguer, JuanMuñoz-Gómez, María JoséDíez, CristinaMicán, RafaelPérez-Elías, María-JesúsGarcía-Fraile, Lucio JesúsPeraire, JoaquinSuárez-García, InésJimenez-Sousa, Maria AngelesFernandez-Rodriguez, AmandaVazquez-Alcaraz, MonicaRyan, PabloGonzález-García, JuanJarrin Vera, InmaculadaMas-Lloret, VicenteResino, SalvadorMartinez, Isidoro2024-11-152024-11-152022-03J Infect. 2022 Mar;84(3):418-467.0163-4453https://pmc.ncbi.nlm.nih.gov/articles/PMC8574204/https://hdl.handle.net/20.500.12105/25518engVoRhttp://creativecommons.org/licenses/by-nc-nd/4.0/ACE2AntibodiesCOVID-19HIVSARS-CoV-2Spike proteinAntibodies, NeutralizingAntibodies, ViralCOVID-19HIV InfectionsHumansImmunity, HumoralSARS-CoV-2Spike Glycoprotein, CoronavirusSimilar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19Attribution-NonCommercial-NoDerivatives 4.0 International34752819843418-46710.1016/j.jinf.2021.11.0021532-2742The Journal of infectionopen access